Apimeds Pharmaceuticals US, Inc (APUS) has a market capitalization of $2.36M and trades at $1.88. The 52-week range is 1.609-40.31.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -15.7, Earnings Per Share (EPS) of $-0.12.
The stock has a beta of 3.71, operates in the Healthcare sector.
